Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Aminoethanethiol
2. 2-aminoethanethiol
3. 35s-labeled Cysteamine
4. Becaptan
5. Beta Mercaptoethylamine
6. Beta-mercaptoethylamine
7. Bitartrate, Cysteamine
8. Cystagon
9. Cysteamine
10. Cysteamine Bitartrate
11. Cysteamine Dihydrochloride
12. Cysteamine Hydrobromide
13. Cysteamine Maleate (1:1)
14. Cysteamine Tartrate
15. Cysteamine Tartrate (1:1)
16. Cysteamine Tosylate
17. Cysteamine, 35s Labeled
18. Cysteamine, 35s-labeled
19. Cysteinamine
20. Dihydrochloride, Cysteamine
21. Hydrobromide, Cysteamine
22. Hydrochloride, Cysteamine
23. Mercamine
24. Mercaptamine
25. Mercaptoethylamine
26. Tartrate, Cysteamine
27. Tosylate, Cysteamine
1. 156-57-0
2. 2-aminoethanethiol Hydrochloride
3. Cysteamine Hcl
4. 2-mercaptoethylamine Hydrochloride
5. Mercaptamine Hydrochloride
6. Bekaptan
7. Cysteaminium Chloride
8. Ethanethiol, 2-amino-, Hydrochloride
9. Mercaptoethylamine Hydrochloride
10. Cysteamine (hydrochloride)
11. 2-thioethylamine Hydrochloride
12. Cysteamine Hydrochloride [usan]
13. 2-aminoethane-1-thiol Hydrochloride
14. 2-aminoethanethiol;hydrochloride
15. Beta-mercaptoethylamine Hydrochloride
16. Mfcd00012904
17. Nsc-758692
18. 2-mercaptoethylammonium Chloride
19. Ci-9148
20. If1b771svb
21. Thioethanolamine Hydrochloride
22. 2-aminoethylmercaptan Hydrochloride
23. Nsc-21116
24. Nsc-25116
25. Ncgc00094090-01
26. 2-mercaptoethylamine Hcl
27. Dsstox_cid_25779
28. Dsstox_rid_81121
29. Dsstox_gsid_45779
30. Merkamin Hydrochloride
31. Cysteamine Hydrochloride (usan)
32. Mercamine Hydrochloride
33. Cysteamine Chlorohydrate
34. Usaf Ee-3
35. Cas-156-57-0
36. Cysteaminhydrochlorid
37. Cysteaminhydrochlorid [german]
38. Ccris 3926
39. Eta-mercaptoethylamine Hydrochloride
40. 1-aminoethane-2-thiol Hydrochloride
41. Einecs 205-858-1
42. Nsc 21116
43. Unii-if1b771svb
44. 1-amino-2-mercaptoethane Hydrochloride
45. Ci 9148
46. Ethylamine, 2-mercapto-, Hydrochloride
47. Cysteamine-hcl
48. Ai3-26089
49. Ccris 3619
50. Beta-mercaptoaethylamin Chlorhydrat [german]
51. A-889
52. Beta-mercaptoaethylamin Chlorhydrat
53. Cystaran (tn)
54. Decarboxycystine Hcl
55. Cym-h.hcl
56. Cystadrops
57. Cysteamine Hydrochoride
58. 2-aminoethanethiol-hcl
59. Cysteamine, Hydrochloride
60. Spectrum2_001667
61. Spectrum3_000992
62. Spectrum4_001120
63. Spectrum5_001422
64. (beta)-mea Hydrochloride
65. Ec 205-858-1
66. Schembl51598
67. Kbiogr_001600
68. Mls000028734
69. Cysteamine Hcl [inci]
70. Decarboxycysteine Hydrochloride
71. Spectrum1504226
72. 2-aminoethanthiol Hydrochloride
73. Spbio_001853
74. Mercaptamine; Mea Hydrochloride
75. Chembl1256137
76. Dtxsid8045779
77. 2-amino-ethanethiol Hydrochloride
78. 2-aminoethanethiol, Hydrochloride
79. B-mercaptoethylamine Hydrochloride
80. Kbio3_001903
81. 2-mercaptoethanamine Hydrochloride
82. A-mercaptoethylamine Hydrochloride
83. Cysteamine Hydrochloride, Bioxtra
84. Hms1922h05
85. Pharmakon1600-01504226
86. Bcp15033
87. Hydrochloric Acid 2-aminoethanethiol
88. Tox21_111245
89. Tox21_500749
90. Ac-301
91. Ccg-39094
92. Cysteamine Hydrochloride [mi]
93. Nsc758692
94. S4206
95. Akos007929948
96. Tox21_111245_1
97. Lp00749
98. 2-aminoethanethiol Hydrochloride (1:1)
99. Cysteamine Hydrochloride [vandf]
100. Ncgc00015691-06
101. Ncgc00094090-02
102. Ncgc00094090-03
103. Ncgc00094090-04
104. Ncgc00261434-01
105. As-12111
106. Hy-77591
107. Mercaptamine Hydrochloride [mart.]
108. Smr000059101
109. 2-aminoethanethiol Chloride;cysteamine Hcl
110. Cysteamine Hydrochloride, >=97.0% (rt)
111. Mercaptamine Hydrochloride [who-dd]
112. Db-043323
113. A0296
114. Cysteamine Hydrochloride, Analytical Standard
115. Eu-0100749
116. Ft-0611242
117. Sw219210-1
118. Cysteamine Hydrochloride [orange Book]
119. Cysteamine Hydrochloride, >=98% (titration)
120. Ethanethiol, 2-amino-, Hydrochloride (1:1)
121. A16474
122. C-9520
123. D03635
124. D70222
125. M 6500
126. A809757
127. Sr-01000075546-1
128. Q27280697
129. Cysteamine Hydrochloride, Vetec(tm) Reagent Grade, 98%
130. F2191-0299
131. Cysteamine Hydrochloride, Pharmagrade, Manufactured Under Appropriate Controls For Use As Raw Material In Pharma Or Biopharmaceutical Production.
132. Cysteamine Hydrochloride, Pharmagrade, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production
Molecular Weight | 113.61 g/mol |
---|---|
Molecular Formula | C2H8ClNS |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 113.0065981 g/mol |
Monoisotopic Mass | 113.0065981 g/mol |
Topological Polar Surface Area | 27 Ų |
Heavy Atom Count | 5 |
Formal Charge | 0 |
Complexity | 10 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Cystaran |
PubMed Health | Cysteamine (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | CYSTARAN is a sterile ophthalmic solution containing 6.5 mg/mL of cysteamine hydrochloride, equivalent to 4.4 mg/mL of cysteamine (0.44%) as the active ingredient. Cysteamine is a cystine-depleting agent which lowers the cystine content of cells in p... |
Active Ingredient | Cysteamine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.44% base |
Market Status | Prescription |
Company | Sigma Tau |
2 of 2 | |
---|---|
Drug Name | Cystaran |
PubMed Health | Cysteamine (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | CYSTARAN is a sterile ophthalmic solution containing 6.5 mg/mL of cysteamine hydrochloride, equivalent to 4.4 mg/mL of cysteamine (0.44%) as the active ingredient. Cysteamine is a cystine-depleting agent which lowers the cystine content of cells in p... |
Active Ingredient | Cysteamine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.44% base |
Market Status | Prescription |
Company | Sigma Tau |
Cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.
Cystine Depleting Agents
Compounds and drugs that react with CYSTINE and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat CYSTINOSIS. (See all compounds classified as Cystine Depleting Agents.)
S01XA21
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36907
Submission : 2022-06-03
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-23
Pay. Date : 2023-02-09
DMF Number : 37415
Submission : 2022-08-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32911
Submission : 2019-01-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2597
Submission : 1976-01-16
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?